Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Editorial, Opinion Piece Respond To Closure Of Murdered Abortion Provider Tiller's Clinic
Two newspapers recently published an editorial and an opinion piece in reaction to the announcement that murdered Kansas abortion provider George Tiller"s Wichita clinic would be permanently closed. The clinic was one of a handful in the U.S. offering abortion procedures in the second and third trimesters. Summaries appear below.~ Kansas City Star: The closing of Tiller"s clinic is "a tragedy for American democracy," and the "irrational violence" of his death has "trumped public policy," a Star editorial states. "The basis of civilization is that we agree to submit to the rule of law in order for society to flourish," the editorial says, adding that Tiller"s murder is "antithetical to that principle. It is dismaying to see a killer achieve his objective." The editorial notes that Tiller provided abortion services in "tragic cases" involving women "at risk of infertility or death; fetuses with severe abnormalities; and victims of rape and incest." It continues that the "reduction or loss of that service will create hardships and may put women"s lives at risk." Hospitals and doctors who refer such cases to abortion providers "must reassess the circumstances under which they would perform late-term abortions," according to the editorial. In addition, the "medical profession must take a role in training and supporting doctors willing to provide abortions," and the government and local police "must do all they can to protect a legal medical practice," the editorial says. It concludes, "Democracy demands that we not allow murder to make de facto public policy" (Kansas City Star, 6/11).~ Eric Zorn, Chicago Tribune: The announcement that Tiller"s clinic will remain permanently closed "was simply more proof that violence and intimidation can get results where civil discourse and political process fail," Tribune columnist Zorn writes. "The question isn"t whether prominent foes of abortion rights are being honest with us when they decry Tiller"s violent death and express regret over the means used to achieve an end they"ve sought," Zorn writes, adding, "Some are, I"m sure." He continues that abortion-rights opponents "recognize that ... a movement calling itself "pro-life"can"t also be pro-murder" and "are politically savvy enough to know that the gains won by terrorist acts are grudging and difficult to sustain." He continues that to "make terrorism less effective, and thereby discourage it," abortion-rights advocates, the medical profession, politicians and law enforcement officials "need to reopen that clinic in Wichita and assure its safe operation ... to defy terrorism, if for no other reason." He concludes that "as long as abortion remains legal, this same coalition needs to strive to expand the number of facilities where it"s available" (Zorn, Chicago Tribune, 6/11).
generic viagra online
Registered Dietitians - A Cost Effective Investment In Health For Canadians
Dietitians of Canada (DC) released a report today describing the integral role played by registered dietitians, as members of multi-disciplinary teams that contribute to promoting and supporting health among Canadians. The Role of Registered Dietitians in Primary Health Care: Moving Forward - A National Perspective presents evidence for the cost-effectiveness of nutrition services in the prevention and treatment of chronic conditions such as diabetes, hypertension, cancer and heart disease.
News of the day
Shire Receives Fast Track Designation For Velaglucerase Alfa For Gaucher Disease
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for velaglucerase alfa, its enzyme replacement therapy in development for the treatment of Type I Gaucher disease. Shire is working with the FDA to determine subsequent steps and timing for the filing of its NDA.
Health Insurance

New Pre-Clinical Data On OmniGuide's BeamPath NEURO(TM) Demonstrates Precise Cutting In Brain Tissue

OmniGuide, Inc., the developer of the first and only flexible CO2 laser fiber based on breakthrough photonic bandgap technology, announced the results of a pre-clinical study comparing the Company"s fiber scalpels to conventional incision methods in neurosurgery. In the study, surgeons from the Barrow Neurological Institute reported that careful studies of incisions produced in live brain tissue with fiber delivered CO2 laser radiation produced precise cuts while minimally effecting adjacent brain tissue when compared with a widely used reference technique. The study, led by Drs. Mark Preul, Robert W. Ryan, and Robert Spetzler of the Neurosurgery Research Laboratory, Barrow Neurological Institute, in Phoenix, Arizona, was presented at the annual conference of the American Academy of Neurological Surgeons in San Diego, California. "The study demonstrates that the flexible CO2 laser fiber was easy to use and manipulate under the operating microscope, could be accurately aimed and created precise incisions without the need to touch or manipulate the tissue," said Dr. Preul, Director of the Barrow"s Neurosurgical Research Laboratory. "The device also allows surgeons to cut and coagulate with a single instrument. Given the high absorption of the CO2 laser in water, a smaller area of tissue is affected as deeper incisions are made which indicates that the BeamPath NEURO could be a valuable new tool added to the neurosurgical armamentarium." CO2 lasers were first used in neurosurgery in 1970 but were never widely adopted because the systems available for delivering the laser energy were awkward and surgeons were limited to "line of sight" procedures. OmniGuide"s BeamPath fiber is based on breakthrough fiber technology developed at MIT and exclusively licensed to OmniGuide. The company manufactures the world"s first flexible fibers for CO2 laser surgery. BeamPath fibers empower surgeons to perform delicate cutting and coagulation with minimal thermal tissue damage and ultimate maneuverability, a major advantage. "The study conducted by surgeons from the Barrow Neurological Institute, a world renowned medical center for brain and spine surgery, provides further validation of the safety and efficacy of the BeamPath fiber in neurosurgery. The ability to precisely and hemostatically cut in the brain while minimizing loss of precious brain tissue has a real potential for improving brain tumor removal efficacy," said Yoel Fink, president and CEO of OmniGuide. "Since the launch of the BeamPath NEURO, we"ve seen strong demand for our technology and it is becoming more widely available to a new patient population that will benefit significantly." About OmniGuide, Inc. OmniGuide, Inc., is the worldwide leader in precision optical scalpels for minimally invasive surgery. OmniGuide CO2 laser fiber products are clinically targeted disposable optical scalpels optimized for specific surgical procedures. The Company has recently introduced a line of fiber-enabled, portable, low-cost CO2 lasers for use in operating rooms and surgical suites. The Company designs and manufactures its fiber products in Cambridge, Mass. based on multi-material photonic bandgap fiber technology exclusively licensed from MIT. The Company distributes its products in the U.S. through a direct sales force and in Europe through distribution partners. OmniGuide is committed to developing products that improve and expand surgical treatment options, enhance clinical outcomes, and reduce treatment complexity and cost. OmniGuide has several leading-edge flexible laser fiber scalpels for use in both hospital and office settings; leading brands include the BeamPath(TM) ENT for laryngology, airway and head and neck procedures and BeamPath(TM) OTO for otology procedures and the BeamPath(TM) NEURO for neurosurgery. OmniGuide, Inc


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009